Panniculitis in Dermatomyositis

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Adipose tissue involvement is rare in dermatomyositis. The occurrence of partial or diffuse lipodystrophy is a rare but well-characterized manifestation, particularly in juvenile forms of dermatomyositis. Panniculitis, on the other hand, is exceptional and rarely described in the literature, mostly in the form of clinical cases. Panniculitis in dermatomyositis is exceptional. There are no validated diagnostic criteria or treatment recommendations. Treatment is based, by analogy, on the therapeutic strategy for lupus panniculitis and involves synthetic antimalarials combined with steroids and/or immunosuppressants. The aim of this study is to describe panniculitis in dermatomyositis in order to determine whether there are clinical or histological characteristics that distinguish it from other causes of panniculitis, particularly panniculitis associated with lupus erythematosus.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Healthy Volunteers: f
View:

• Subject aged 1 year and older

• With a confirmed diagnosis of dermatomyositis

• With a confirmed diagnosis of panniculitis

Locations
Other Locations
France
Service de dermatologie - CHU de Strasbourg - France
RECRUITING
Strasbourg
Contact Information
Primary
Dan LIPSKER, MD
dan.lipsker@chru-strasbourg.fr
33 3 88 11 50 48
Time Frame
Start Date: 2025-10-20
Estimated Completion Date: 2028-04-20
Participants
Target number of participants: 20
Sponsors
Leads: University Hospital, Strasbourg, France

This content was sourced from clinicaltrials.gov